 SALT LAKE CITY, Aug. 11, 2020 GLOBE NEWSWIRE -- Health Catalyst, Inc. Nasdaq: HCAT, a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended June 30, 2020. First, let me express our ongoing gratitude to all the heroic national health systems and their front-line workers. We are both grateful and honored that our health system customers have continued to trust us so meaningfully to support them in this time of great need, said Dan Burton, CEO of Health Catalyst. From a financial perspective, I am very pleased with our performance in the second quarter across all areas of our business, including outperforming the mid-point of our guidance for both total revenue and Adjusted EBITDA. In addition to this financial and operational execution, I was particularly pleased to see that our team member overall satisfaction score, as measured by Gallup, ranked in the 99th percentile once again. This past periods score, the second highest in the companys history, was particularly encouraging as we adapted to a remote-only culture. Mr. Burton continued: We are hosting our seventh annual Healthcare Analytics Summit in September. While the format will be virtual this year, we continue to believe this conference represents a meaningful opportunity for Health Catalyst to continue to provide thought leadership within the healthcare data and analytics ecosystem, while carefully listening to our customers and prospects as we further cultivate and deepen those relationships. The theme of this years conference will be healthcare analytics in the new normal, and we are fortunate to feature many of the leading voices in the country as our keynote speakers.Financial Highlights for the Three Months Ended June 30, 2020 Key Financial Metrics Three Months Ended Year over June 30, Year 2020 2019 Change GAAP Financial Data:in thousands, except percentages Technology revenue25,487 20,085 27 Professional services revenue17,772 16,719 6 Total revenue43,259 36,804 18 Loss from operations15,640 9,363 67 Net loss27,183 10,694 154 Other Non-GAAP Financial Data:1 Adjusted Technology Gross Profit17,493 13,072 34 Adjusted Technology Gross Margin69 65 Adjusted Professional Services Gross Profit3,730 6,193 40 Adjusted Professional Services Gross Margin21 37 Total Adjusted Gross Profit21,223 19,265 10 Total Adjusted Gross Margin49 52 Adjusted EBITDA4,188 5,749 27 ___ 1 These measures are not calculated in accordance with generally accepted accounting principles in the United States GAAP. See the accompanying Non-GAAP Financial Measures section below for more information about these financial measures, including the limitations of such measures, and for a reconciliation of each measure to the most directly comparable measure calculated in accordance with GAAP.Financial Outlook Health Catalyst provides forward-looking guidance on total revenue, a GAAP measure, and Adjusted EBITDA, a non-GAAP measure.For the third quarter of 2020, we expect: Total revenue between 43.0 million and 46.0 million, and Adjusted EBITDA between 8.9 million and 6.9 millionFor the full year of 2020, we expect: Total revenue between 177.2 million and 181.2 million, and Adjusted EBITDA between 25.5 million and 22.5 millionWe have not reconciled guidance for Adjusted EBITDA to net loss, the most directly comparable GAAP measure, and have not provided forward-looking guidance for net loss, because there are items that may impact net loss, including stock-based compensation, that are not within our control or cannot be reasonably predicted.Quarterly Conference Call Details The company will host a conference call to review the results today, Tuesday, August 11, 2020 at 5:00 p.m. E.T. The conference call can be accessed by dialing 1-877-295-1104 for U.S. participants, or 1-470-495-9486 for international participants, and referencing participant code 2285626. A live audio webcast will be available online at A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.About Health Catalyst Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage the cloud-based data platformpowered by data from more than 100 million patient records and encompassing trillions of factsas well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.Available InformationHealth Catalyst intends to use its Investor Relations website as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.Forward-Looking Statements This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements include statements regarding our future growth and our financial outlook for Q3 2020. Forward-looking statements are subject to risks and uncertainties and are based on potentially inaccurate assumptions that could cause actual results to differ materially from those expected or implied by the forward-looking statements. Actual results may differ materially from the results predicted, and reported results should not be considered as an indication of future performance.Important risks and uncertainties that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: i changes in laws and regulations applicable to our business model; ii changes in market or industry conditions, regulatory environment and receptivity to our technology and services; iii results of litigation or a security incident; iv the loss of one or more key customers or partners; v the impact of COVID-19 on our business and results of operation; and vi changes to our abilities to recruit and retain qualified team members. For a detailed discussion of the risk factors that could affect our actual results, please refer to the risk factors identified in our SEC reports, including, but not limited to the Annual Report on Form 10-K for the year ended December 31, 2019 filed with the SEC on February 28, 2020 and the Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2020 expected to be filed with the SEC on or about August 12, 2020. All information provided in this release and in the attachments is as of the date hereof, and we undertake no duty to update or revise this information unless required by law.Condensed Consolidated Balance Sheets in thousands, except share and per share data, unaudited As of As of June 30, December 31, 2020 2019 Assets Current assets: Cash and cash equivalents104,185 18,032 Short-term investments248,932 210,245 Accounts receivable, net34,426 27,570 Deferred costs455 937 Prepaid expenses and other assets8,955 7,455 Total current assets396,953 264,239 Property and equipment, net3,835 4,295 Intangible assets, net29,435 25,535 Operating lease right-of-use assets15,417 3,787 Other assets2,337 810 Goodwill18,419 3,694 Total assets466,396 302,360 Liabilities and stockholders equity Current liabilities: Accounts payable2,398 3,622 Accrued liabilities7,487 8,944 Acquisition-related consideration payable3,164 2,192 Deferred revenue35,173 30,653 Operating lease liabilities1,963 2,806 Total current liabilities50,185 48,217 Long-term debt, net of current portion163,480 48,200 Acquisition-related consideration payable, net of current portion 1,860 Deferred revenue, net of current portion2,176 1,459 Operating lease liabilities, net of current portion13,913 1,654 Contingent consideration liability1,457 Other liabilities1,223 326 Total liabilities232,434 101,716 Commitments and contingencies Stockholders equity: Common stock, 0. 